Company: TAK
Filing Date: 2025-07-30
Form Type: 6-K
Source: 0001395064-25-000120
Chunk: 17

Company: TAKEDA PHARMACEUTICAL CO LTD
Filing Date: 2025-07-30
Form: 6-K
Chunk 17
---
)

Loans :

| Name of Loan                                    
 (Face Value if Denominated in Foreign Currency) |     | Execution    |     | Maturity     |     | Carrying Amount 
 (Billion JPY)   |       |
| Bilateral Loans                                 |     | March 2016 ~ 
 April 2024   |     | March 2026 ~ 
 April 2031   |     |                 | 200.0 |
| Bilateral Loans (USD 500 million)               |     | June 2025    |     | July 2025    |     |                 |  72.1 |
| Syndicated Hybrid Loans (Subordinated Loans)    |     | October 2024 |     | October 2084 |     |                 |  40.0 |
| Other                                           |     |              |     |              |     |                 |   0.1 |
| Total                                           |     |              |     |              |     |                 | 312.1 |

On April 25, 2025, Takeda repaid JPY 10.0 billion in Bilateral Loans falling due. On June 12, 2025, Takeda issued JPY 184.0 billion in unsecured JPY denominated senior bonds (“JPY Bonds”) with maturity dates ranging from June 12, 2030, to June 12, 2035. The proceeds of the JPY Bonds will be used to redeem commercial paper. Following this, on June 23, 2025, Takeda redeemed USD 800 million of unsecured U.S. dollar-denominated senior notes on their maturity date. Takeda has also rolled over USD 500 million Bilateral Loan, which was originally drawn down on March 31, 2025, on a monthly basis until July 3, 2025.

*Amounts presented in the above explanation for Bonds and Loans are based on the principal amount.

#### Equity
Total Equity as of June 30, 2025 was JPY 6,866.2 billion ( JPY -69.8 billion). This decrease was primarily due to the increase in Treasury Shares ( JPY -49.3 billion ), mainly attributed to an acquisition of Takeda's own shares.

<div align='center'>10</div>

Takeda Pharmaceutical Company Limited (4502)

Earnings Report ( Kessan Tanshin ) for the Three-month

Period Ended June 30, 202